Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-22-057966

Chief Financial Officer sold 11,095 shares at $3.57 ($39,609)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thomsen Jillian B. Chief Financial Officer 2022-11-16 Sale −11,095 $3.57 $39,609 323,764 D: show line 1 in the form
Open-market sales · 11,095 sh · avg $3.57 · $39,609
Loading xslF345X03/doc4.xml…